Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia

NCT00767091 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease
Apathy
no Dementia

Interventions

DRUG: rivastigmine
DRUG: placebo

Sponsor

University Hospital, Lille